A Phase 3 interventional study of Photoplethysmography in Polyp of Large Intestine, Colorectal Neoplasms and Crohn Disease, sponsored by University Hospital, Caen. Completed at 1 site in France. Open to participants aged 18 Years to 95 Years. Per ClinicalTrials.gov, last updated 2026-04-02.
Sponsored by University Hospital, Caen · Phase 3, Interventional, and Other
The purpose of this study is to determine whether hemodynamic optimization with photoplethysmography (ClearSight, Edwards Lifesciences, Irvine, CA) during colorectal surgery could decrease the incidence of perioperative complications.
All patients received the photoplethysmography monitoring, but the monitor was blinded in the control group.
5,599 studies on the registry are indexed under Colorectal Neoplasms; 1,459 are open to participants now.
This study's enrollment of 160 is above the median of 77 across 4,123 interventional studies indexed under Colorectal Neoplasms.
Browse Colorectal Neoplasms studies →University Hospital, Caen is the lead sponsor of 505 studies on the registry; 80 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Control group using a hemodynamic standard protocol
Hemodynamic optimization using Photoplethysmography device (ClearSight, Edwards Lifesciences, Irvine, CA)
Device: Photoplethysmography
Use Photoplethysmography for hemodynamic optimization during colorectal perioperative period
Incidence of patients presenting at least one complication after colorectal surgery
Two independent experts defined the presence of complication using an a priori classification.
Time frame: Up to 28 days after surgery (length of hospital stay)
All complications happening after colorectal surgery
Time frame: Up to 28 days after surgery (length of hospital stay)
Real length of hospital stay
Time frame: Up to 28 days after surgery (length of hospital stay)
Perioperative mortality
Time frame: 28 days after surgery
Medico economic evaluation of cost of treatment
Medico economic evaluation of photoplethysmography use will be assessed with a specific unit of measure, using cost of treatment.
Time frame: Up to 28 days after surgery (length of hospital stay)
This study is completed, as verified in May 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Caen